FDA authorizes pre-exposure prevention option for COVID-19
For pre-exposure prevention of COVID-19 in adults and pediatric individuals 12 years of age and older weighing at least 40 kg
Drugs
The Center for Drug Evaluation and Research (CDER) ensures that safe and effective drugs are available to improve the health of the people in the United States
Topic Paragraphs
COVID-19 Updates
Q&A for Consumers | Hand Sanitizers and COVID-19
Learn how the FDA and its partners are addressing the COVID-19 outbreak
Know your treatment options for COVID-19
The FDA approved one drug and many more are being tested in clinical trials
Recent News
FDA issues guidance on the incorporation of immunogenicity information
Feb 4 - Assists applicants with human prescription biological products labeling
FDA approves treatment for adults with rare form of anemia
Feb 4 - First approval for certain patients with cold agglutinin disease
Possible increased risk of death with Ukoniq (umbralisib)
Feb 3 - FDA investigating this cancer drug that treats two types of lymphoma
Trending Topics
Disposal of Unused Medicines: What You Should Know
The short video shows you how to properly get rid of unused or expired medication
High Blood Pressure–Understanding the Silent Killer
It can lead to many serious problems that’s why it’s important to know your risk factors
BeSafeRx: Your Source for Online Pharmacy Information
Explore resources and tools so you can safely buy prescription medicines online
CENTER FOR DRUG EVALUATION AND RESEARCH
Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
Toll Free
(855) 543-3784
(301) 796-3400
Hours Available
CDER Division of Drug Information
Paragraph Header (Column 2)
FOR UPDATES ON TWITTER FOLLOW
Paragraph Header (Column 2)
FOR UPDATES ON TWITTER FOLLOW
@FDA_Drug_Info
Your source for the latest drug information.
Know the moment it happens.